News & Perspective

Jan 09, 2007

Jan 09, 2007

FDA approves refrigerated form of FluMist

(CIDRAP News) – The US Food and Drug Administration (FDA) has approved a refrigerated form of FluMist, the nasal-spray influenza vaccine, which should be more convenient for providers than the current formulation, MedImmune Inc. announced yesterday.

FluMist, a live attenuated vaccine first approved in 2003, is currently approved for use in healthy children and adults from ages 5 to 49 years.